Desk›Healthcare› Themis Medicare Ltd
Themis Medicare Ltd
BSE 530199 · NSE THEMISMED · ISIN INE083B01024 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹125.40
-0.40%
BSE close, 28 August 2026
₹1,154.94 cr
9.2 cr shares · Micro cap
₹350.70 cr
as published
38.6× · 3.55×
EPS ₹3.25 · BV ₹35.32
342.24 / -14.19
₹ cr, as filed
29
8 selected · 28%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -15.3% |
|---|---|
| Against 52-week low | +92.9% |
| Day change | -0.40% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹3.25 |
|---|---|
| Price / earnings | 38.58× |
| Price / book | 3.55× |
| Book value — derived, price ÷ P/B | ₹35.32 |
| Return on equity | 9.20% |
| Operating margin | 55.48% |
| Net margin | 33.05% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 9.20%
- ROE as published
- 9.20%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 86.96 | 28.74 | 3.12 | 55.48% | 33.05% |
| Mar-26 · Q | 76.53 | 1.97 | 0.21 | 9.72% | 2.57% |
| FY25-26 | 342.24 | -14.19 | -1.54 | 2.22% | -4.15% |
Quarter on quarter
- Revenue, quarter on quarter
- +13.6%
- Net profit, quarter on quarter
- +1,358.9%
- Operating margin, quarter on quarter
- +4,576 bps
Disclosure profile 29 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Credit Rating | 2 |
| Investor Presentation | 2 |
| KMP | 2 |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 8 |
| Procedural | |
| SAST | 5 |
| AGM / EGM | 4 |
| General | 3 |
| Charter Amendment | 2 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 21 |
| Total | 29 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
29 filings · 8 selected · busiest 2026-08-13
Filing rhythm · the twelve most recent
2026-09-082026-10-09
SelectedProcedural
Filings
29 in the window · 6 earlier on record
-
9 October 2026 ·
Credit Rating
Kindly refer to our intimation of credit rating.
Company Update / Credit Rating View filing →
-
1 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please refer to our Scrutinizer's Report of 56th Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Kindly refer to the attachment.
AGM/EGM / AGM View filing →
-
30 September 2026 ·
-
30 September 2026 ·
Amendments to Memorandum & Articles of Association
Please refer to the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
30 September 2026 ·
Amendments to Memorandum & Articles of Association
Please refer to the attachment.
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Kindly refer to the Outcome of 56th Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
24 September 2026 ·
Announcement Under Regulation 30 Of LODR - Withdrawal Of Proposed Preferential Issue.
Please refer to our intimation under Regulation 30 for withdrawal of proposed preferential issue of 45,95,795 convertible equity warrants.
Company Update / General View filing →
-
23 September 2026 ·
Closure of Trading Window
Please refer to our Intimation of closure of Trading window for the declaration of un-audited financial results for the quarter and half year ending 30.09.2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Corporate Action -Fixed Record Date For Dividend For FY 2025-26.
Please refer to the attachment.
Corp. Action / Record Date View filing →
-
9 September 2026 ·
Newspaper Publication
Please refer to Newspaper publication for Notice of 56th AGM scheduled on 30th September, 2026.
Company Update / Newspaper Publication View filing →
-
8 September 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Please refer to our BRSR for F.Y. 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Please refer to our Annual Report for F.Y. 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
8 September 2026 ·
Notice Of 56Th Annual General Meeting Scheduled On 30.09.2026
Please refer to the Notice of 56th AGM and Annual Report for F.Y. 2025-26
AGM/EGM / AGM View filing →
-
17 August 2026 ·
Change Of Company Secretary / Compliance Officer's E-Mail ID And Updation Of E-Mail Id Of RTA,
Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
Company Update / General View filing →
-
14 August 2026 ·
Newspaper Publication
Newspaper Publication of Un-audited Financial Results for the quarter ended 30th June, 2026
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Investor Presentation
Investors Presentation for the quarter ended 30.06.2026
Company Update / Investor Presentation View filing →
-
13 August 2026 ·
Investor Presentation
Investors Presentation for the quarter ended 30.06.2026
Company Update / Investor Presentation View filing →
-
13 August 2026 ·
Announcement Under Regulation 30(5) Of SEBI (LODR)- Updates
Please refer to the attachment.
Company Update / General View filing →
-
13 August 2026 ·
Resignation of Company Secretary / Compliance Officer
Please refer to the attachment.
Company Update / Resignation of Company Secretary / Compliance Officer View filing →
-
13 August 2026 ·
Appointment of Company Secretary and Compliance Officer
Please refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
Company Update / Appointment of Company Secretary / Compliance Officer View filing →
-
13 August 2026 ·
Results- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026.
Kindly refer to the attachment.
Result / Financial Results View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026.
Please refer to the outcome of the Board Meeting held on 13th August 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
31 July 2026 ·
Board Meeting Intimation for Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30Th June, 2026 And Limited Review Reports Of The Statutory Auditors Thereon
Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Board Meeting / Board Meeting View filing →
-
31 July 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Vividhmargi Investments Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026 ·
Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026 ·
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026 ·
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
RSS feed for Themis Medicare Ltd · the 50 most recent filings